Table 2.
Clinicopathological characteristics of involved colon cancer patients.
| LCC patients (n=121) | RCC patients (n=121) | P | |
|---|---|---|---|
| Age (years), means±SD | 61.16±12.369 | 61.61±13.291 | 0.783 |
| Gender, n (%) | 0.156 | ||
| Male | 81 (66.9%) | 91 (75.2%) | |
| Female | 40 (33.1%) | 30 (24.8%) | |
| Tumor size, n (%) | 0.047 * | ||
| <5 cm | 83 (68.6%) | 68 (56.2%) | |
| ≥5 cm | 38 (31.4%) | 53 (43.8%) | |
| Tumor differentiation, n (%) | 0.938 | ||
| Well | 24 (19.8%) | 12 (9.9%) | |
| Moderate | 63 (52.1%) | 85 (70.2%) | |
| Poor | 34 (28.1%) | 24 (19.8%) | |
| DNA mismatch repair, n (%) | 0.123 | ||
| dMMR | 16 (13.2%) | 25 (20.7%) | |
| pMMR | 105 (86.8%) | 96 (79.3%) | |
| T stage, n (%) | 0.525 | ||
| T1 | 9 (7.4%) | 11 (9.1%) | |
| T2 | 20 (16.5%) | 23 (19.0%) | |
| T3 | 73 (60.3%) | 69 (57.0%) | |
| T4 | 19 (15.7%) | 18 (14.9%) | |
| N stage, n (%) | 0.032 * | ||
| N0 | 37 (30.6%) | 55 (45.5%) | |
| N1 | 52 (43.0%) | 41 (33.9%) | |
| N2 | 32 (26.4%) | 25 (20.7%) | |
| AJCC stage, n (%) | 0.021 * | ||
| I | 21 (17.4%) | 27 (22.3%) | |
| II | 31 (25.6%) | 45 (37.2%) | |
| III | 69 (57.0%) | 49 (40.5%) | |
| Venous invasion, n (%) | 0.556 | ||
| Negative | 88 (72.7%) | 92 (76.0%) | |
| Positive | 33 (27.3%) | 29 (24.0%) | |
| Perineural Invasion, n (%) | 0.593 | ||
| Negative | 79 (65.3%) | 75 (62.0%) | |
| Positive | 42 (34.7%) | 46 (38.0%) | |
| Tumor budding, n (%) | 0.686 | ||
| Negative | 23 (19.0%) | 15 (12.4%) | |
| Weak | 57 (47.1%) | 73 (60.3%) | |
| Moderate | 27 (22.3%) | 28 (23.1%) | |
| Strong | 14 (11.6%) | 5 (4.1%) |
*P<0.05.